Health CanadaType I
Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers)
Published: August 14, 2023Recall ID: 64118Category: generalCountry: Canada
Reason for Recall / Hazard
Contamination
Product Description & Identification
Continue taking your medication unless you have been advised to stop by your health care provider. You do not need to return your medication to your pharmacy. Not treating your condition may pose a greater health risk.Talk to your health care provider if you are taking a recalled product and are concerned about your health.If you have questions about the recall, contact Apotex Inc. at 1-888-628-0732 or by email at apotex4315@sedgwick.com.Report any health product-related side effects or complaints to Health Canada.
Affected Products
Apo-Acyclovir Tablets
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64118 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/apo-acyclovir-tablets-ndma-impurity-updated-new-product-and-lot-numbers |
| Issue | Contamination |
| Title | Apo-Acyclovir Tablets: NDMA impurity (Updated with new product and lot numbers) |
| Product | Apo-Acyclovir Tablets |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-08-14 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Continue taking your medication unless you have been advised to stop by your health care provider. You do not need to return your medication to your pharmacy. Not treating your condition may pose a greater health risk.Talk to your health care provider if you are taking a recalled product and are concerned about your health.If you have questions about the recall, contact Apotex Inc. at 1-888-628-0732 or by email at apotex4315@sedgwick.com.Report any health product-related side effects or complaints to Health Canada. |